NGENLA (somatrogon-ghla) injection
NGENLA is a prescription medicine used to treat GHD. FDA approved somatrogon-ghla (brand name NGENLA) is not (yet) registered or available in India but on request Indian patient can buy NGENLA at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
NGENLA (somatrogon-ghla) injection
Tezacaftor/ivacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 6 years of age and older. It is only used for patients who have two copies of F508del mutation, or who have at least one mutation in their CF transmembrane conductance regulator (CFTR) gene.
NGENLA is a human growth hormone analog indicated for treatment of pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone.
Somatrogon, sold under the brand name Ngenla, is a medication for the treatment of growth hormone deficiency. Somatrogon is a glycosylated protein constructed from human growth hormone and a small part of human chorionic gonadotropin which is appended to both the N-terminal and C-terminal. Somatrogon is a human growth hormone analog.
The most common side effects include reactions at the site of injection, headache, and fever.
Somatrogon was approved for medical use in Australia in November 2021, in the European Union in February 2022, and in the United States in June 2023
NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 2023
—————-
Current Indication: Treat pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone.
—————-
Marketed By: Pfizer Inc
—————-
Approval Date: : 2023
—————-
Active ingredient: somatrogon-ghla
Injection:
• 24 mg/1.2 mL (20 mg/mL) single-patient-use prefilled pen that delivers a dose in 0.2 mg increments.
• 60 mg/1.2 mL (50 mg/mL) single-patient-use prefilled pen that delivers a dose in 0.5 mg increments.
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ NGENLA (somatrogon-ghla) injection ”. Confirmation of the order for NGENLA (somatrogon-ghla) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for NGENLA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Get Access to Treatment – NGENLA
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
NGENLA Sourcing & Delivery
Alleviare India specializes in sourcing and supplying NGENLA, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of NGENLA in India.
How much does NGENLA cost in the India?
Kindly reach out to us for NGENLA (somatrogon-ghla) injection price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import SYMDEKO to India?
To import somatrogon-ghla – NGENLA, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is NGENLA available in India?
NGENLA – somatrogon-ghla is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of NGENLA (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for NGENLA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is somatrogon-ghla available in India?
Yes, FDA approved somatrogon-ghla (brand name NGENLA) is not (yet) registered or available in India but on request Indian patient can buy NGENLA at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand NGENLA (somatrogon-ghla) injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
